LIfT BioSciences

About:

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

Website: http://www.liftbiosciences.com/

Top Investors: Innovate UK, Lifespan Vision Ventures, Jonathan Milner, MassChallenge, Starbloom Capital

Description:

LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to produce different types of Immunomodulatory Alpha Neutrophils (IMAN®s) at scale from iPSCs for a wide range of different purposes as a mono or combo. LIfT BioSciences was founded in 2016 and headquartered in London, England.